^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Anti-CD19-CAR

i
Other names: Anti-CD19-CAR, CD19 Chimeric Antigen Receptor (CAR) redirected autologous T-cells therapy
Associations
Company:
Beijing Doing Biomedical
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations